Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thorstensson

Showing results (301-310 of 342) with videos related to

Pageof 35
Sort By:
Breast Cancer Research and Treatment|January 5, 2000
Biomarkers for local recurrence after breast-conservation--a nested case-control studyK Dalberg, E Eriksson, L Kanter, et al.
Journal of Medical Virology|May 1, 1991
HIV reverse transcriptase inhibiting antibodies detected by a new technique: relation to p24 and gp41 antibodies, HIV antigenemia and clinical variablesM Neumüller, A Karlsson, J Lennerstrand, et al.
Journal of Virology|February 11, 1999
Primary human immunodeficiency virus type 2 (HIV-2) isolates, like HIV-1 isolates, frequently use CCR5 but show promiscuity in coreceptor usageA Mörner, A Björndal, J Albert, et al.
Biomolecules|October 27, 2022
Gene Delivery of Manf to Beta-Cells of the Pancreatic Islets Protects NOD Mice from Type 1 Diabetes DevelopmentKailash Singh, Orian Bricard, Jeason Haughton, et al.
The Journal of General Virology|June 20, 2001
Cross-protection against mucosal simian immunodeficiency virus (SIVsm) challenge in human immunodeficiency virus type 2-vaccinated cynomolgus monkeysLilian Walther-Jallow, Charlotta Nilsson, Johan Söderlund, et al.
The Journal of General Virology|November 15, 2008
CTA1-DD adjuvant promotes strong immunity against human immunodeficiency virus type 1 envelope glycoproteins following mucosal immunizationChristopher Sundling, Karin Schön, Andreas Mörner, et al.
The Journal of General Virology|March 22, 2002
Immunization with recombinant modified vaccinia virus Ankara can modify mucosal simian immunodeficiency virus infection and delay disease progression in macaquesCharlotta Nilsson, Gerd Sutter, Lilian Walther-Jallow, et al.
Musculoskeletal Care|January 31, 2013
Similar problem in the activities of daily living but different experience: a qualitative analysis in six rheumatic conditions and eight European countriesTanja Stamm, Robin Hieblinger, Carina Boström, et al.
Vaccine|May 12, 2001
Enhanced simian immunodeficiency virus-specific immune responses in macaques induced by priming with recombinant Semliki Forest virus and boosting with modified vaccinia virus AnkaraC Nilsson, B Mäkitalo, P Berglund, et al.
Breast Cancer Research : BCR|February 16, 2012
Gene expression profiling of primary male breast cancers reveals two unique subgroups and identifies N-acetyltransferase-1 (NAT1) as a novel prognostic biomarkerIda Johansson, Cecilia Nilsson, Pontus Berglund, et al.
Pageof 35

Showing results (301-310 of 342) with videos related to

Sort By:
Pageof 35
Breast Cancer Research and Treatment|January 5, 2000
Biomarkers for local recurrence after breast-conservation--a nested case-control studyK Dalberg, E Eriksson, L Kanter, et al.
Journal of Medical Virology|May 1, 1991
HIV reverse transcriptase inhibiting antibodies detected by a new technique: relation to p24 and gp41 antibodies, HIV antigenemia and clinical variablesM Neumüller, A Karlsson, J Lennerstrand, et al.
Journal of Virology|February 11, 1999
Primary human immunodeficiency virus type 2 (HIV-2) isolates, like HIV-1 isolates, frequently use CCR5 but show promiscuity in coreceptor usageA Mörner, A Björndal, J Albert, et al.
Biomolecules|October 27, 2022
Gene Delivery of Manf to Beta-Cells of the Pancreatic Islets Protects NOD Mice from Type 1 Diabetes DevelopmentKailash Singh, Orian Bricard, Jeason Haughton, et al.
The Journal of General Virology|June 20, 2001
Cross-protection against mucosal simian immunodeficiency virus (SIVsm) challenge in human immunodeficiency virus type 2-vaccinated cynomolgus monkeysLilian Walther-Jallow, Charlotta Nilsson, Johan Söderlund, et al.
The Journal of General Virology|November 15, 2008
CTA1-DD adjuvant promotes strong immunity against human immunodeficiency virus type 1 envelope glycoproteins following mucosal immunizationChristopher Sundling, Karin Schön, Andreas Mörner, et al.
The Journal of General Virology|March 22, 2002
Immunization with recombinant modified vaccinia virus Ankara can modify mucosal simian immunodeficiency virus infection and delay disease progression in macaquesCharlotta Nilsson, Gerd Sutter, Lilian Walther-Jallow, et al.
Musculoskeletal Care|January 31, 2013
Similar problem in the activities of daily living but different experience: a qualitative analysis in six rheumatic conditions and eight European countriesTanja Stamm, Robin Hieblinger, Carina Boström, et al.
Vaccine|May 12, 2001
Enhanced simian immunodeficiency virus-specific immune responses in macaques induced by priming with recombinant Semliki Forest virus and boosting with modified vaccinia virus AnkaraC Nilsson, B Mäkitalo, P Berglund, et al.
Breast Cancer Research : BCR|February 16, 2012
Gene expression profiling of primary male breast cancers reveals two unique subgroups and identifies N-acetyltransferase-1 (NAT1) as a novel prognostic biomarkerIda Johansson, Cecilia Nilsson, Pontus Berglund, et al.
Pageof 35